Drug Shortage Report for PLAVIX
| Report ID | 205398 |
| Drug Identification Number | 02238682 |
| Brand name | PLAVIX |
| Common or Proper name | PLAVIX |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90 |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-09-26 |
| Estimated end date | 2024-01-12 |
| Actual end date | 2023-12-11 |
| Shortage status | Resolved |
| Updated date | 2023-12-12 |
| Company comments | Oversales. Blister pack available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-12-12 | English | Compare |
| v6 | 2023-12-11 | French | Compare |
| v5 | 2023-12-11 | English | Compare |
| v4 | 2023-10-02 | French | Compare |
| v3 | 2023-10-02 | English | Compare |
| v2 | 2023-09-28 | French | Compare |
| v1 | 2023-09-28 | English | Compare |
Showing 1 to 7 of 7